Treatment with NO-synthase inhibitor, methylene blue moderates the decrease in serum leptin concentration in streptozotocin-induced diabetes. | Charles Explorer

Treatment with NO-synthase inhibitor, methylene blue moderates the decrease in serum leptin concentration in streptozotocin-induced diabetes.

Publikace na Fakulta tělesné výchovy a sportu |

1999

Abstrakt

Leptin, streptozocin, diabetes, methylene blue.

Osoby